Citas bibligráficas
Atequipa, R., Damian, J. (2019). Implementación de un programa de seguimiento farmacoterapéutico y su efecto en la calidad de vida en pacientes hipertensos en el centro materno infantil “Laura Rodríguez Dulanto Duksil”. Comas, 2018 [Tesis, Universidad Inca Garcilaso de la Vega]. https://hdl.handle.net/20.500.11818/4341
Atequipa, R., Damian, J. Implementación de un programa de seguimiento farmacoterapéutico y su efecto en la calidad de vida en pacientes hipertensos en el centro materno infantil “Laura Rodríguez Dulanto Duksil”. Comas, 2018 [Tesis]. : Universidad Inca Garcilaso de la Vega; 2019. https://hdl.handle.net/20.500.11818/4341
@misc{renati/860516,
title = "Implementación de un programa de seguimiento farmacoterapéutico y su efecto en la calidad de vida en pacientes hipertensos en el centro materno infantil “Laura Rodríguez Dulanto Duksil”. Comas, 2018",
author = "Damian Ciriaco, Jessica Alejandrina",
publisher = "Universidad Inca Garcilaso de la Vega",
year = "2019"
}
The objective of the present work was to evaluate the effect of the implementation of a pharmacotherapeutic follow-up program on the quality of life in hypertensive patients treated at the Laura Rodríguez Dulanto Duksil Mother and Child Center in the district of Comas, 2018. Methodology observational study, longitudinal, quantitative approach, explanatory level with pre experimental design. The sample consisted of 35 hypertensive patients treated at the Laura Rodríguez Dulanto Duksil Mother and Child Center in the district of Comas in 2018. A univariate analysis was used taking into account absolute and relative frequencies, as well as an inferential analysis: in which To determine the distribution of the variables by means of the Kolmogorov - Smirnov test, in such a way that when a p≥0.05 results (normal distribution), the Student t test was used for two related samples and for the p <0.05 (distribution not normal) and the Wilcoxon test (for two related samples). Results the mood in hypertensive patients before the therapeutic program showed an average score of 19.31, being higher than the average score of 9.03 after the therapeutic program, evidencing a significant difference (p = 0.000). Somatic manifestations in hypertensive patients before the therapeutic program showed an average score of 10.31, being higher than the average score of 4.17 after the therapeutic program, evidencing a significant difference (p = 0.000). The quality of life in hypertensive patients before the therapeutic program showed an average score of 29.63, being higher than the average score of 13.20 obtained after the therapeutic program, evidencing a significant difference (p = 0.000). Conclusions: the implementation of a pharmacotherapeutic follow-up program improved the quality of life in hypertensive patients treated at the Laura Rodríguez Dulanto Duksil Mother and Child Center in the district of Comas, 2018.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons